Resource Utilization in Cardiac DiseaseLloyd W. Klein, James E. Calvin Despite recent advances in the diagnosis and treatment of various cardiac illnesses, including ischemic, valvular and cardiomyopathic disease, the most cost-effective means of employing laboratory testing and treatment modalities remains an issue in most practice settings. With the advent of managed care and vigilant third-party payer evaluation of the use of diagnostic tests and hospital length of stay, the most effective medical and economic method of managing everyday cardiac illness is a question that arises daily in practice. To this end, we have selected well-known and widely published experts in cardiac diagnosis and therapy to develop practical and informative approaches outlining the most cost-effective methods of patient management. The topics include the entire range of cardiac diseases and emphasize the economic impact on decision-making. We develop guidelines and present general strategies for the practicing cardiologist and general internist. Additionally, the editors, who have 10 years of experience in this area, discuss the methods necessary to bring critical pathways and practice guidelines into clinical use. Both hospital and out-patient phases of illness are considered. Special concerns of hospital, private practice managed care and group practice settings are specifically addressed. |
Contents
COST EFFECTIVE EVALUATION OF CHEST PAIN | 1 |
MANAGEMENT OF STABLE ANGINA PECTORIS | 19 |
MANAGEMENT OF UNSTABLE ANGINA USING RISK STRATIFICATION METHODS | 41 |
EVIDENCE BASED MANAGEMENT OF ACUTE MYOCARDIAL INFARCTION | 57 |
PLATELET GLYCOPROTEIN IIBIIIA INTEGRIN INHIBITION IN ACUTE MYOCARDIAL INFARCTION | 93 |
RISK FACTOR MODIFICATION | 107 |
HYPERTENSION DIAGNOSIS AND TREATMENT | 127 |
SELECTION OF BALLOON CATHETER THERAPY FOR PATIENTS WITH MITRAL AND AORTIC VALVE STENOSIS | 149 |
Resource Utilization in Atrial Fibrillation | 181 |
CONGESTIVE HEART FAILURE | 211 |
CORONARY INTERVENTION | 225 |
CARDIOGENIC SHOCK | 239 |
THE USE OF CLINICAL PRACTICE GUIDELINES IN CARDIOLOGY | 251 |
INFORMATION SYSTEM REQUIREMENTS | 269 |
MANAGEMENT OF PATIENTS WITH LIFETHREATENING VENTRICULAR TACHYARRHYTHMIAS FOCUS ON THE PREEMINENT ROLE ... | 283 |
305 | |
Other editions - View all
Common terms and phrases
abciximab ACE inhibitors acute myocardial infarction agents angina pectoris angioplasty anticoagulation antihypertensive aortic arrhythmias aspirin assessment atrial fibrillation balloon benefit beta blockers blood pressure cardiac output cardiovascular cardioversion catheter catheterization chest pain cholesterol chronic Circulation clinical database clinical trials Coll Cardiol commissurotomy congestive heart failure coronary angiography coronary artery disease coronary intervention cost decrease diabetes diagnosis diastolic diuretics dose drug echocardiography effective electrocardiogram Engl evaluation exercise GP IIb/IIIa heart disease hemodynamic heparin hospital hypertension implantation improve increase intravenous ischemia ischemic left atrial left ventricular dysfunction lipid Medicine mortality outcome percutaneous perfusion pharmacologic physician placebo procedure PTCA PTMC pulmonary randomized trial reduced reperfusion resource utilization revascularization risk factors sinus rhythm stenosis strategy streptokinase stress testing stroke surgery surgical symptoms syndrome systolic Table thallium thrombolytic therapy thrombus TIMI treatment unstable angina valve replacement valvuloplasty ventricular function ventricular tachycardia women